ABVC vs MSFT · rev $796.0K vs P/E 39, rev $331.84B
ABVC Biopharma Inc (ABVC) versus Microsoft Corporation (MSFT) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
Microsoft Corporation (MSFT) is a software - infrastructure company listed on US. It is led by Satya Nadella.
Latest reported ABVC revenue for 2025-09-30 was $796.0K. Net income was -$1.3M. ABVC currently screens at market cap $35.9M.
Latest reported MSFT revenue for 2026-06-30 was $331.84B. Net income was $133.75B. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
ABVC currently screens at market cap $35.9M. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
Not investment advice. Open the ABVC and MSFT stock pages for the full models.
Not investment advice.